Activity of gemcitabine in patients with non-small cell lung cancer: A multicentre, extended phase II studyU. Gatzemeier, Maurizio Voi, Frances A. Shepherd et al.|European Journal of Cancer|1996Cited by 242
Phase I First-in-Human Study of CUDC-101, a Multitargeted Inhibitor of HDACs, EGFR, and HER2 in Patients with Advanced Solid TumorsToshio Shimizu, Anthony W. Tolcher, Muralidhar Beeram et al.|Clinical Cancer Research|2014Cited by 82